Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Catheter Cardiovasc Interv Retrieve available abstracts of 84 articles: HTML format Text format

Single Articles

January 2019
1. JIA S, Zhao Y, Yang J, Zhao X, et al
   Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
   Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
   PubMed     Text format     Abstract available
   
   
   December 2018
2. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
   Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
   Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
   PubMed     Text format     Abstract available
   
   
   November 2018
3. KIM YH, Her AY, Jeong MH, Kim BK, et al
   Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
   Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
   PubMed     Text format     Abstract available
   
   
   
4. GE J, Li J, Dong B, Ning X, et al
   Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
   Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
   PubMed     Text format     Abstract available
   
   
   October 2018
5. GE Z, Baber U, Claessen BE, Farhan S, et al
   The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
   Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27860.
   PubMed     Text format     Abstract available
   
   
   
6. FABRIS E, Van't Hof A, Hamm CW, Lapostolle F, et al
   Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
   Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27921.
   PubMed     Text format     Abstract available
   
   
   September 2018
7. OGUNBAYO GO, Misumida N, Ayoub K, Hailemariam Y, et al
   Temporal trends, characteristics and outcomes of fibrinolytic therapy for ST-elevation myocardial infarction among patients 80 years or older.
   Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27833.
   PubMed     Text format     Abstract available
   
   
   
8. PEPE M, Cafaro A, Paradies V, Signore N, et al
   Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction.
   Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27863.
   PubMed     Text format     Abstract available
   
   
   
9. WANG YS, Zhang J, Li YF, Chen BR, et al
   A pilot clinical study of adjunctive therapy with selective intracoronary hypothermia in patients with ST-segment elevation myocardial infarction.
   Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27864.
   PubMed     Text format     Abstract available
   
   
   
10. DAVID SW, Khan ZA, Patel NC, Metzger DC, et al
    Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27905.
    PubMed     Text format     Abstract available
    
    
    
11. SHETABI K, Ullah R, Patel R, Wilson T, et al
    Contemporary practice pattern of revascularization in a large tertiary care referral center in non-ST elevation myocardial infarction: A propensity-matched 10-year experience.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27839.
    PubMed     Text format     Abstract available
    
    
    
12. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Text format     Abstract available
    
    
    
13. KIMURA T, Nishibori Y, Miki K, Maruyama T, et al
    Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27787.
    PubMed     Text format     Abstract available
    
    
    
14. IBRAHIM H, Kaltenbach LA, Hess CN, Recchia T, et al
    Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27816.
    PubMed     Text format     Abstract available
    
    
    
15. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
    Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
    PubMed     Text format     Abstract available
    
    
    
16. BOI A, Sanna F, Rossi A, Loi B, et al
    Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
    PubMed     Text format     Abstract available
    
    
    
17. BRUGALETTA S, Cequier A, Alfonso F, Iniguez A, et al
    MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27825.
    PubMed     Text format     Abstract available
    
    
    
18. KORNOWSKI R, Levi A
    Periprocedural myocardial infarction in chronic total occlusion: The challenge of precise diagnosis and prognostication.
    Catheter Cardiovasc Interv. 2018;92:486-487.
    PubMed     Text format     Abstract available
    
    
    
19. CLAESSEN BE, Mehran R
    How to manage chronic total occlusions in the setting of acute myocardial infarction complicated by cardiogenic shock?
    Catheter Cardiovasc Interv. 2018;92:464-465.
    PubMed     Text format     Abstract available
    
    
    July 2018
20. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
    Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
    PubMed     Text format     Abstract available
    
    
    May 2018
21. GUL B, Kozuma K, Haimi I, Zhao W, et al
    Sex disparities in acute myocardial infarction care and outcomes.
    Catheter Cardiovasc Interv. 2018 May 10. doi: 10.1002/ccd.27622.
    PubMed     Text format     Abstract available
    
    
    
22. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed     Text format    
    
    
    April 2018
23. MCNEICE A, Nadra IJ, Robinson SD, Fretz E, et al
    The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2018 Apr 26. doi: 10.1002/ccd.27648.
    PubMed     Text format     Abstract available
    
    
    March 2018
24. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed     Text format    
    
    
    
25. GOINS AE, Rayson R, Caughey MC, Sola M, et al
    Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27625.
    PubMed     Text format     Abstract available
    
    
    
26. GOLDSWEIG AM, Wang Y, Forrest JK, Cleman MW, et al
    Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27576.
    PubMed     Text format     Abstract available
    
    
    February 2018
27. BRILAKIS ES, Eckman P
    The five key "ingredients" for improving outcomes in cardiogenic shock complicating acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:462-463.
    PubMed     Text format     Abstract available
    
    
    
28. BUTMAN S
    KISS for in-stent restenosis.
    Catheter Cardiovasc Interv. 2018;91:434.
    PubMed     Text format     Abstract available
    
    
    
29. URETSKY BF
    All stent strut malappositions are not created equal.
    Catheter Cardiovasc Interv. 2018;91:376-377.
    PubMed     Text format     Abstract available
    
    
    
30. CHATTERJEE A, Hillegass WB
    The promise of effective P2Y12 platelet receptor pretreatment: Not crushed yet.
    Catheter Cardiovasc Interv. 2018;91:251-252.
    PubMed     Text format     Abstract available
    
    
    
31. BRILAKIS ES, Krestyaninov O
    Wanted: Expert operators for coronary chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:180-181.
    PubMed     Text format     Abstract available
    
    
    
32. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Text format     Abstract available
    
    
    
33. BUTMAN SM
    If not now, why are you waiting?
    Catheter Cardiovasc Interv. 2018;91:265-266.
    PubMed     Text format     Abstract available
    
    
    
34. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Text format     Abstract available
    
    
    January 2018
35. XU N, Tang XF, Yao Y, Zhao X, et al
    Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Jan 13. doi: 10.1002/ccd.27495.
    PubMed     Text format     Abstract available
    
    
    December 2017
36. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Text format     Abstract available
    
    
    
37. BASIR MB, Schreiber T, Dixon S, Alaswad K, et al
    Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27427.
    PubMed     Text format     Abstract available
    
    
    
38. GIUSTINO G, Dangas GD
    Ischemia-reperfusion injury and ischemic post-conditioning in acute myocardial infarction: Lost in translation.
    Catheter Cardiovasc Interv. 2017;90:1068-1069.
    PubMed     Text format     Abstract available
    
    
    November 2017
39. GOLDSTEIN JA
    Peri-procedural myocardial infarction: Plaques and patients "at-risk".
    Catheter Cardiovasc Interv. 2017;90:915-916.
    PubMed     Text format     Abstract available
    
    
    October 2017
40. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed     Text format    
    
    
    
41. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Text format     Abstract available
    
    
    September 2017
42. YUDI MB, Farouque O, Andrianopoulos N, Ajani AE, et al
    Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27325.
    PubMed     Text format     Abstract available
    
    
    
43. WATANABE H, Morimoto T, Shiomi H, Kawaji T, et al
    Chronic total occlusion in non-infarct-related artery is associated with increased short-and long-term mortality in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock (from the CREDO-Kyoto AMI registry).
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27330.
    PubMed     Text format     Abstract available
    
    
    
44. GIUSTINO G, Dangas GD
    Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2017;90:396-397.
    PubMed     Text format     Abstract available
    
    
    August 2017
45. AGRAWAL M, Hakeem A, Ahmed Z, Uretsky BF, et al
    Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2017;90:225-232.
    PubMed     Text format     Abstract available
    
    
    July 2017
46. MANGELS DR, Giri J, Hirshfeld J, Wilensky RL, et al
    Robotic-assisted percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Jul 19. doi: 10.1002/ccd.27205.
    PubMed     Text format     Abstract available
    
    
    
47. MIGLIORINI A, Valenti R, Vergara R, Grazia De Gregorio M, et al
    Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
    Catheter Cardiovasc Interv. 2017;90:72-77.
    PubMed     Text format     Abstract available
    
    
    June 2017
48. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Text format     Abstract available
    
    
    
49. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Text format     Abstract available
    
    
    May 2017
50. BRENER MI, Bush A, Miller JM, Hasan RK, et al
    Influence of radial versus femoral access site on coronary angiography and intervention outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 May 25. doi: 10.1002/ccd.27043.
    PubMed     Text format     Abstract available
    
    
    
51. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Text format     Abstract available
    
    
    
52. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
    Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
    PubMed     Text format     Abstract available
    
    
    
53. SETO AH, Dehghani P, Shah B, Anwaruddin S, et al
    Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.
    Catheter Cardiovasc Interv. 2017;89:1028-1034.
    PubMed     Text format     Abstract available
    
    
    
54. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Text format     Abstract available
    
    
    
55. WERNER GS, Glaser P, Coenen A, Moehlis H, et al
    Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates.
    Catheter Cardiovasc Interv. 2017;89:1005-1012.
    PubMed     Text format     Abstract available
    
    
    
56. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Text format     Abstract available
    
    
    
57. ANDRADE PB, Mattos LA, Rinaldi FS, Bienert IC, et al
    Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
    Catheter Cardiovasc Interv. 2017;89:976-982.
    PubMed     Text format     Abstract available
    
    
    April 2017
58. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available
    
    
    
59. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
    Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
    PubMed     Text format     Abstract available
    
    
    March 2017
60. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
    Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
    PubMed     Text format     Abstract available
    
    
    
61. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
    Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
    Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
    PubMed     Text format     Abstract available
    
    
    
62. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available
    
    
    
63. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
    The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
    PubMed     Text format     Abstract available
    
    
    
64. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available
    
    
    
65. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available
    
    
    
66. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
    One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
    PubMed     Text format     Abstract available
    
    
    
67. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
    Ischemic postconditioning during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
    PubMed     Text format     Abstract available
    
    
    
68. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Text format     Abstract available
    
    
    
69. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available
    
    
    February 2017
70. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available
    
    
    
71. VISVESWARAN GK, Cohen M, Seliem A, DiVita M, et al
    A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26908.
    PubMed     Text format     Abstract available
    
    
    December 2016
72. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
    Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
    PubMed     Text format     Abstract available
    
    
    November 2016
73. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
    Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
    PubMed     Text format     Abstract available
    
    
    
74. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
    Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
    PubMed     Text format     Abstract available
    
    
    
75. SHAH R, Matin K, Rogers KC, Rao SV, et al
    Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
    PubMed     Text format     Abstract available
    
    
    September 2016
76. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
    Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
    PubMed     Text format     Abstract available
    
    
    
77. SUKUL D, Seth M, Dixon SR, Zainea M, et al
    Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
    PubMed     Text format     Abstract available
    
    
    August 2016
78. KANG SJ, Yang DH, Koo HJ, Yun SC, et al
    Intravascular ultrasound-derived morphological predictors of myocardial ischemia assessed by stress myocardial perfusion computed tomography.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26710.
    PubMed     Text format     Abstract available
    
    
    
79. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Text format     Abstract available
    
    
    
80. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Text format     Abstract available
    
    
    
81. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Text format     Abstract available
    
    
    
82. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
    Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
    PubMed     Text format     Abstract available
    
    
    
83. RHEUDE TA, Xhepa E, Byrne RA
    Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26694.
    PubMed     Text format     Abstract available
    
    
    July 2016
84. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: